Active Ingredient History

NOW
  • Now
Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. It is administered by injection under the skin.   Wikipedia

More Chemistry
  • Mechanisms of Action:
  • Multi-specific: No
  • Black Box: Yes
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

Australia

$400.7138 - $2320.3333
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

abp 501 | adalimumab | adalimumab-adaz | adalimumab-adbm | adalimumab-atto | adalimumab (genetical recombination) | amjevita | d2e7 | humira | ibi303 | lu200134 | lu-200134 | msb11022

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue